© 2002 Nature Publishing Group http://immunol.nature.com
A RTICLES
Human epithelial cells trigger
dendritic cell–mediated allergic
inflammation by producing TSLP
Vassili Soumelis1, Pedro A. Reche1, Holger Kanzler1,Wei Yuan1, Gina Edward1, Bernhart
Homey1,2, Michel Gilliet1, Steve Ho1, Svetlana Antonenko1, Annti Lauerma3, Kathleen Smith1,
Daniel Gorman1, Sandra Zurawski1, Jon Abrams1, Satish Menon1,Terri McClanahan1, Rene de
Waal-Malefyt1, Fernando Bazan1, Robert A. Kastelein1 and Yong-Jun Liu1
Published online: 10 June 2002, doi:10.1038/ni805
Whether epithelial cells play a role in triggering the immune cascade leading to T helper 2 (T H2)-type
allergic inflammation is not known.We show here that human thymic stromal lymphopoietin (TSLP)
potently activated CD11c + dendritic cells (DCs) and induced production of the T H2-attracting
chemokines TARC (thymus and activation-regulated chemokine; also known as CCL17) and MDC
(macrophage-derived chemokine; CCL22).TSLP-activated DCs primed naïve T H cells to produce the
proallergic cytokines interleukin 4 (IL-4), IL-5, IL-13 and tumor necrosis factor-α, while downregulating IL-10 and interferon-γ. TSLP was highly expressed by epithelial cells, especially
keratinocytes from patients with atopic dermatitis.TSLP expression was associated with Langerhans
cell migration and activation in situ.These findings shed new light on the function of human TSLP and
the role played by epithelial cells and DCs in initiating allergic inflammation.
About 20% of the population in Western countries suffers from allergic diseases, which include asthma, allergic rhinitis, atopic dermatitis
and food allergy1. Allergic inflammation is the result of a complex
immunological cascade that leads to dysregulated production of T
helper type 2 (TH2)-derived cytokines such as interleukin 4 (IL-4), IL5 and IL-132–4, which trigger immunoglobulin E (IgE) production,
eosinophilia and mucus production5–7. Dendritic cells (DCs), which
are professional antigen-presenting cells8, play an important role in
the pathogenesis of allergic diseases9–11. However, the initial signal
that primes DCs to induce T cells to produce proallergic TH2
cytokines is unknown. Epithelial cells are located at the sites of allergen entry into the body and interact closely with DCs in situ.
However, it is not known whether DCs play a role in triggering the
allergic immune cascade. Although skin keratinocytes and mucosal
epithelial cells produce proinflammatory cytokines such as IL-1, IL6, IL-8, granulocyte-macrophage colony-stimulating factor (GMCSF) and tumor necrosis factor-α (TNF-α) after activation12, none of
these cytokines explain the mechanism that underlies the induction of
allergic inflammation.
Thymic stromal lymphopoietin (TSLP) is an IL-7–like cytokine,
cloned from a murine thymic stromal cell line13. The TLSP receptor is
a heterodimer that consists of the IL-7 receptor α chain (IL-7Rα) and
a common γ-like receptor chain called TSLP receptor (TSLPR)14–17.
Mouse TSLP supports murine early B and T cell developments18,19 and
1
does not appear to have any biological effects on murine DCs (unpublished data). In contrast, human TSLP activates CD11c+ DCs, but does
not appear to have any direct biological effects on B cells, T cells, NK
cells, neutrophils or mast cells17. This is in accordance with the coexpression of IL-7Rα chain and TSLPR mRNA in CD11c+ DCs, but not
in other cell types. We show here that human TSLP potently activated
human CD11c+ DCs, which subsequently primed naïve TH cells to produce high concentrations of IL-13, IL-5 and TNF-α, moderate amounts
of IL-4 and down-regulate IL-10 and interferon-γ (IFN-γ). TSLP is
highly expressed by epithelial cells of inflamed tonsils and keratinocytes of atopic dermatitis. Thus, TSLP represents a key epithelial
cell or keratinocyte-derived cytokine that directly triggers DC-mediated allergic inflammation.
Results
TSLP potently activates human CD11c+ DCs
We compared the effects of TSLP, IL-7, CD40 ligand (CD40L)and
lipopolysaccharide (LPS) on human CD11c+ DC activation. TSLP, IL-7,
CD40L and LPS all up-regulated surface HLA-DR, CD40, CD80, CD86
and CD83 on DCs when compared with medium alone (Fig. 1a). Whereas
TSLP induced the most CD40 and CD80 expression on DCs, CD40L
induced more HLA-DR and CD83. Like CD40L, TSLP not only activated DCs, but also maintained the survival of DCs in 24-h cultures, as
shown by annexin V staining (Fig. 1a) and cell counts (data not shown).
DNAX, 901 California Avenue, Palo Alto, CA 94304, USA. 2Department of Dermatology, Heinrich-Hein University, Moorenstr. 5, 40225 Dusseldorf, Germany. 3Department
of Dermatology, Helsinki University Hospital, Meihlandentie 2, Helsinki, Finland. Correspondence should be addressed to Y.-J. L. (yong-jun.liu@dnax.org).
http://immunol.nature.com
•
july 2002
•
volume 3 no 7
•
nature immunology
673
© 2002 Nature Publishing Group http://immunol.nature.com
A RTICLES
TSLP-DCs induce CD4+ T cell expansion
The ability of TSLP to up-regulate HLA-DR and costimulatory molecules
was blocked by two neutralizing monoclonal antibodies (mAbs)—5E5
and 12F3—that were specific for human TSLP (Fig. 1b). The two TSLP
mAbs did not block the up-regulation of HLA-DR and costimulatory molecules on DCs induced by CD40L, IL-7 or LPS (data not shown). These
data indicated that the observed effects of TSLP on CD11c+ DCs were
TSLP-specific. Morphologically, both TSLP-activated DCs (referred to
hereafter as TSLP-DCs) and CD40L-activated DCs (referred to hereafter
as CD40L-DCs) showed long dendrites and expressed more HLA-DR and
DC–lysosome-associated membrane protein (DC-LAMP, which is a DC
activation marker) compared to DCs in medium alone or IL-7–activated
DCs (referred to hereafter as IL-7–DCs) (Fig. 1c).
Compared to CD40L-DCs, LPS-activated DCs (referred to hereafter as
LPS-DCs) or IL-7–DCs, TSLP-DCs induced stronger naïve CD4+ T
cell proliferation in an allogeneic mixed lymphocyte reaction (Fig. 2a).
At a 1:150 ratio of DCs:T cells, TSLP-DCs still induced allogeneic
naïve CD4+ T cell proliferation that was about three-times stronger than
that induced by CD40L-DCs (Fig. 2a). After 6 days of culture, TSLPDCs induced a 7.5- to 9-fold increase in total T cell numbers, which
was more than that induced by CD40L-DCs, LPS-DCs or IL-7–DCs
(Fig. 2b). Therefore, human TSLP represents one of the most potent
DC activation factors, and TSLP-DCs induce the most marked allogeneic naïve CD4+ T cell proliferation and expansion.
a
Figure 1.TSLP potently activates
CD11c+ DCs and maintains their
survival. (a) TSLP strongly up-regulates HLA-DR, CD40, CD80, CD86
and CD83 compared to medium
alone, and it potently up-regulates
CD40 and CD80 expression compared to other DC activators
(CD40L, IL-7 and LPS). Filled histograms represent staining of DC activation markers; open histograms represent the isotype control. Numbers
indicate the mean fluorescence intensity (MFI). The percentage of annexin
V+ apoptotic DCs was also greatly
reduced after 24 h of culture with
TSLP (24%), CD40L (25%) and LPS
(18%) compared with those cultured
with medium (69%) or IL-7 (43%).
Data represent one of six independent experiments. (b) Surface CD80
expression by DCs is strongly induced
by TSLP, which is specifically blocked
by rat anti-TSLP (mAbs 5E5 and
12F3). Numbers indicate the MFI for
CD80 expression. Data represent one
of three independent experiments.
(c) Morphological analysis of DCs on
cytospins. Major histocompatibility
complex (MHC) class II staining of
CD11c+ DCs cultured with (A) medium (B) IL-7 (C) CD40L or (D) TSLP.
MHC class II (blue) and DC-LAMP
(red) double-staining of DCs cultured
with (E) CD40L or (F) TSLP.
b
c
674
A
B
C
D
E
F
nature immunology
•
volume 3 no 7
•
july 2002
•
http://immunol.nature.com
A RTICLES
© 2002 Nature Publishing Group http://immunol.nature.com
a
Figure 2. Naïve CD4+ T cell proliferation and expansion with
DCs activated by TSLP and other activators. (a) TSLP-DCs
induced the strongest CD4+ T cell proliferation after 5 days of culture,
as assessed by [3H]thymidine incorporation both at high (1:6) and low
(1:150) DC:T ratios. (b) TSLP-DCs induced the highest CD4+ T cell
expansion after 6 days of culture. Results are expressed as fold expansion compared to the initial T cell number (50,000 cells). Data represent
five independent experiments; horizontal bars indicate the median.
b
TSLP-DCs induce TH2 development
tured with DCs at a 1:5 ratio for 6 days; they were then washed to
remove all cytokines, restimulated for 24 h with anti-CD3 and antiCD28 and then cytokine production was measured in the culture supernatant by ELISA. TSLP-DCs induce naïve CD4+ T cells to produce large
amounts of IL-13, IL-5 and TNF-α and a moderate amount of IL-4 (Fig.
4a). Compared to DCs cultured with medium alone or other activators,
TSLP-DCs induced naïve CD4+ T cells to produce the lowest amounts
of the anti-inflammatory cytokine IL-10 and the TH1 cytokine IFN-γ
(Fig. 4a). The ability of TSLP-DCs to induce naïve CD4+ T cells to produce high IL-13 and TNF-α, moderate IL-4 and low IFN-γ and IL-10
was confirmed by intracellular cytokine staining (Fig. 4b). Therefore,
TSLP-DCs induced naïve CD4+ T cells to produce a unique set of
cytokines that was distinct from a TH1 profile (IFN-γ) or a classical TH2
profile (IL-4, IL-5 and IL-10). Compared with CD4+ T cells activated by
DCs cultured in medium, IL-7–DCs, CD40L-DCs or LPS-DCs, CD4+ T
cells primed with TSLP-DCs produced the highest amounts of TNF-α,
one of the most potent proinflammatory cytokines. In contrast, TSLPDCs inhibited IL-10 as well as IFN-γ production by CD4+ T cells.
Therefore, TSLP-DCs may induce robust TH2 allergic inflammation
by inducing naïve CD4+ T cells to produce large amounts of IL-13 and
IL-5 and a moderate amount of IL-4 in the presence of TNF-α and in the
absence of two physiologic inhibitors of TH2 inflammation, IL-10 and
IFN-γ26,27. In addition, TSLP-DCs may further enhance TH2-mediated
inflammation by producing chemokines such as TARC and MDC, which
may preferentially recruit TH2 cells into the original inflamed tissues28–30.
Most DC activation signals, such as CD40L and LPS, induce DCs to produce the proinflammatory cytokines IL-1α/β, IL-6 and IL-1220,21 and
prime naïve CD4+ T cell differentiation towards TH122–24. We performed a
global quantitative mRNA screening of 11 different cytokines—IL-1α,
IL-1β, IL-4, IL-6, IL-10, IL-12p35, IL-12p40, IL-13, IL-18, IL-23p19 and
TNF-α—and 12 different chemokines— thymus and activation-regulated
chemokine (TARC also known as CCL17), DCCK1, macrophage-derived
chemokine (MDC or CCL22), monocyte chemoattractant protein 1
(MCP-1 or CCL2), MCP-2 (or CCL8), MCP-3 (or CCL7), MCP-4 (or
CCL13), eotaxin (or CCL11), macrophage inflammatory protein (MIP-3β
or CCL19), monokine induced by γ interferon (MIG or CXCL9),
RANTES (or CCL5) and IL-8 (or CXCL8)—which have potential effects
either on naïve CD4+ T cell polarization or the migration of TH1 or TH2
cells. Unlike CD40L-DCs and LPS-DCs, TSLP-DCs did not produce
mRNA for all the proinflammatory cytokines tested, but did produce high
levels of mRNA for the chemokines TARC and MDC (data not shown).
Enzyme-linked immunosorbent assay (ELISA) analyses confirmed at the
protein level that TLSP-DCs did not produce detectable amounts of the
proinflammatory cytokines IL-1β, IL-6, IL-12p70 and TNF-α, but did
produce high amounts of the chemokines TARC and MDC (Fig. 3).
TARC and MDC preferentially attract CCR4-expressing TH2 cells25.
The capacity of TSLP-DCs to polarize naïve CD4+ T cells was compared to DCs cultured with medium, IL-7, CD40L or LPS. Naïve human
CD4+CD45RA+ T cells purified from adult peripheral blood were cul-
Figure 3. Cytokine and chemokine production by DCs activated with TSLP. TSLP-DCs did not produce inflammatory cytokines compared to CD40L-DCs or LPSDCs, but produce high amounts of the TH2-attracting chemokines TARC and MDC. Data represent one of five experiments.
http://immunol.nature.com
•
july 2002
•
volume 3 no 7
•
nature immunology
675
A RTICLES
Figure 4. Cytokine production by naïve
CD4+ T cells primed for 6 days with
TSLP-DCs. (a) TSLP-DCs prime CD4+ T
cells to produce the highest amounts of IL4, IL-5, IL-13 and TNF-α, but lower amounts
of IFN-γ and IL-10, compared to mediumactivated DCs, CD40L-DCs, LPS-DCs or IL7-DCs. Data represent one of six independent experiments. (b) Intracellular cytokine
staining of T cells after 5-h restimulation
with PMA and ionomycin shows similar
results. Data represent one of three independent experiments.
© 2002 Nature Publishing Group http://immunol.nature.com
a
TSLP protein expression by
epithelial cells
Human tonsils contain two types of
epithelium: crypt epithelium, which
frequently harbors viruses and bacteria and represents the site of antigenentry and constitutive inflammation,
and squamous epithelium. Using the
mAb 12F3, we showed that TSLP is
expressed by crypt epithelial cells,
which were in close contact with cells
expressing DC-LAMP in five different tonsillar samples tested31 (Fig. 6).
In all tonsil samples tested, only a
few small foci of TSLP expression
were found within the apical part of
the squamous epithelium (Fig. 7).
The expression of TSLP was associated with the infiltration of DCLAMP+-activated DCs (Fig. 7a,b)
and the concurrent loss of langerin+
Langerhans cells within the squamous epithelium (Fig. 7c,d). Staining
with 12F3 was specific for TSLP
because recombinant TSLP, but not
IL-7, completely blocked the staining
and rat Ig isotype control antibody
did not give any positive staining
(data not shown). These results suggested that TSLP may contribute to
constitutive inflammation within the crypt epithelium and sporadic
inflammation within the squamous epithelium.
b
TSLP mRNA expression
To further understand the biology and pathophysiology of TSLP,
expression of TSLP mRNA was analyzed by real-time quantitative
polymerase chain reaction (PCR) in a panel of cDNA libraries from different cells or cell lines and a panel of purified primary cells (cell purity >99%) (Fig. 5). TSLP expression was not found in most hematopoietic cell types, including B cells, T cells, NK cells, granulocytes,
macrophages, monocyte subsets and DC subsets; the exception was
mast cells. Mast cells activated by mAbs that cross-link high-affinity
IgE receptors express high amounts of TSLP. Human primary nonhematopoietic cells, such as skin keratinocytes, epithelial cells, smooth
muscle cells and lung fibroblasts, cultured in growth medium, also
expressed TSLP at high amounts, suggesting that these cells have the
ability to produce TSLP (Fig. 5). Compared to cells cultured in medium, bronchial smooth muscle cells and skin keratinocytes activated by
IL-4, IL-13 and TNF-α or TNF-α and IL-1β expressed higher TSLP.
TSLP expression was not found in endothelial cells. Therefore, TSLP
mRNA was mainly expressed by stromal cells, epithelial cells and mast
cells, but not other hematopoietic cell types or endothelial cells.
676
nature immunology
•
volume 3 no 7
High TSLP expression in atopic dermatitis
To investigate whether TSLP expression is associated with TH2-type
allergic inflammation in vivo, TSLP protein expression was analyzed in
skin lesions, including atopic dermatitis (a TH2-mediated allergic disease), nickel-induced contact dermatitis (an IFN-γ–producing
T cell–mediated allergic disease) and cutaneous lupus erythematosus
samples. Although TSLP was undetectable in normal skin (11 separate
samples) (Fig. 8a), high expression of TSLP was found in the keratinocytes of acute (ten patients, Fig. 8b,c) and chronic atopic dermatitis (five patients, Fig. 8d–f). Isotype control–staining of an adjacent
section (as shown in Fig. 8d) gave a negative result. Expression of
TSLP was found mainly in keratinocytes of the apical layers of the epidermis, which ranged from small foci to the whole apical areas in both
acute and chronic atopic dermatitis. The characteristics of these
patients with atopic dermatitis are summarized (Table 1).
•
july 2002
•
http://immunol.nature.com
© 2002 Nature Publishing Group http://immunol.nature.com
A RTICLES
a
b
c
d
Figure 5. Quantification of TSLP mRNA levels in different human
hematopoietic and stromal cell types. High levels of TSLP mRNA were detected in epithelial cells, different types of stromal cells and mast cells, but not in other
hematopoietic cells.
Nonlesional skin samples were available for 9 of 15 atopic dermatitis patients. None of these samples stained positive for TSLP, which
confirmed the specificity of TSLP for atopic dermatitis lesions and its
absence from normal skin. Using Fisher’s exact test, we were able to
show that the difference between the normal skin group and atopic dermatitis group was statistically significant (P < 0.001). TSLP was not
found in skin lesions from nickel-induced allergy contact dermatitis
(Fig. 8h) or cutaneous lupus erythematosus (Fig. 8i) patients.
Figure 6. Expression of TSLP by crypt epithelial cells of human inflamed
tonsils. (a,b) Double staining of TSLP (red) and DC-LAMP (blue). Expression of TSLP
by crypt epithelial cells (red), which were in close association with DC-LAMP+ lymphocytes and DCs (blue). (a) Magnification: ×100 (b) magnification: ×200. (c,d)
Double staining of TSLP (red) and langerin (blue). TSLP expression (red) by crypt
epithelial cells, but not by squamous epithelial cells characterized by the presence of
langerin+ Langerhans cells (blue). Langerin+ Langerhans cells within the epidermis do
not express DC-LAMP. (c) Magnification: ×100; (d) magnification: ×200.
TSLP associates with Langerhans cell activation
skin, or nonlesional skin of from atopic dermatitis samples, many langerin+ Langerhans cells were found within the epidermis, but not within the dermis (Fig. 9a); and no DC-LAMP+ activated DCs were found
in either the epidermis or the dermis (Fig. 9b). Strong TSLP expression
in atopic dermatitis was associated with the disappearance of langerin+
To investigate whether TSLP expression in atopic dermatitis is associated with DC activation, TSLP was stained together with either langerin (the Langerhans cell marker) or DC-LAMP (the DC activation
marker) in double immunohistology experiments (Fig. 9). In normal
a
b
c
d
Figure 7. Sporadic expression of TSLP by squamous epithelial cells of inflamed tonsils is associated with the presence of activated DC-LAMP+ DCs.
(a,b) Double staining with TSLP (red) and DC-LAMP (blue), showing DC-LAMP+ DCs within the epithelium area, which is positive for TSLP. (c,d) Double staining of TSLP
(red) and langerin (blue), showing a decreased number of langerin+ Langerhans cells within the TSLP-expressing epithelium.
http://immunol.nature.com
•
july 2002
•
volume 3 no 7
•
nature immunology
677
© 2002 Nature Publishing Group http://immunol.nature.com
A RTICLES
Langerhans cells within the epidermis
(Fig. 9c) and the concurrent appearance
of many DC-LAMP+ activated DCs
within the dermis (Fig. 9d). Many of the
DC-LAMP+ activated DCs within the
dermis expressed langerin, suggesting
that epidermal Langerhans cells may be
activated and migrate into the dermis
(Fig. 9d). These results suggested that
TSLP expression by keratinocytes in
atopic dermatitis lesions may contribute
directly to the activation of Langerhans
cells, which may then migrate into the
draining lymph nodes and prime allergen-specific TH2 responses.
Table 1. Characteristics of patients with atopic dermatitis
Patient
TSLPa
Age
Sex
1
2
3
4
5
6
7
8
9
10
+++
++
++
+++
+++
++
+++
++
+
+
23
20
40
34
30
66
53
25
40
21
M
F
M
M
F
F
F
M
F
F
Prick testc
IgEd
50–75%
50–75%
75%
NAf
>75%
25%
35%
40%
3%
85%
Rhinitis
Asthma
Rhinitis
NAf
Asthma, rhinitis
Rhinitis
Nog
Nog
Nog
Rhinitis
+
+
+
NAf
+
+
+
+
+
+
1250
5350
45260
NAf
795
2230
99
NAf
983
NAf
Chronic atopic dermatitish
11
+++
26
M
30%
Nog
–
NAf
12
+++
49
M
5%
Nog
–
210
13
+++
35
F
10%
Nog
+
1207
g
+
NAf
14
+
24
M
15%
No
15
+
45
F
15%
Nog
+
4572
a
Quantification of the TSLP staining on skin sections: weak and focal (+), intermediate (++), strong and diffused (+++).
b
Skin surface area involved at the time of biopsy. cFor the prick test, + indicates a positive test to at least one allergen.
d
Total blood IgE concentrations (IU/ml): normal values are 0–200 IU/ml or 0–110 IU/ml, depending on the center. eSkin
lesions were <1-week-old. fNot available. gAbsence of other allergies. hSkin lesions were >1-week-old.
We have shown here that the epithelial
cells of skin and mucosa may directly
interact with DCs during allergic
inflammation by producing TSLP.
Human TSLP is a DC activator that
displays several unique features compared with other DC activation factors,
such as CD40L, LPS or IL-7. It induced more CD40 and CD80
expression on DCs compared to other activators, activated DCs to
induce strong naïve CD4+ T cell proliferation and expansion, did not
induce DCs to produce proinflammatory cytokines (instead it produced the TH2-attracting chemokines TARC and MDC) and it
endowed DCs with the ability to prime naïve CD4+ T cells to produce
large amounts of IL-13, IL-5 and TNF-α and moderate amounts of
IL-4. However, expression of the anti-inflammatory cytokine IL-10
and the TH1 cytokine IFN-γ were inhibited. These features suggested
that TSLP represents a critical mediator in uncontrolled allergic
inflammation.
Activation of DCs appears to be a critical step in the pathogenesis of
TH2-mediated allergic inflammation. Although DCs from allergic individuals preferentially induce a TH2-type response32–36, the molecular
mechanism underlying the signaling of DCs to induce TH2 allergic diseases is not understood. Our findings that TSLP is highly expressed by
a
b
c
d
e
f
678
Other allergies
Acute atopic dermatitise
Discussion
g
Surface areab
i
h
nature immunology
Figure 8. Expression of TSLP in
atopic dermatitis. (a) Nonlesional
skin from an atopic dermatitis patient.
(b,c) Samples from acute atopic dermatitis patients. (d–f) Samples from
chronic atopic dermatitis patients.
(g) An adjacent section of d, showing
negative staining with isotype control.
(h) Lesion from a nickel-induced contact
allergic dermatitis patient. (i) Lesion
from a cutaneous lupus erythematosus
patient.TSLP stained red.
•
volume 3 no 7
•
july 2002
•
http://immunol.nature.com
© 2002 Nature Publishing Group http://immunol.nature.com
A RTICLES
Figure 9. TSLP expression in atopic dermatitis associates with
Langerhans cell migration and activation. (a) Double staining of TSLP (red)
and DC-LAMP (blue) with a normal skin sample, showing no TSLP expression and
no DC-LAMP+ activated DCs within the epidermis or dermis. (b) Double staining
of TSLP (red) and langerin (blue), showing the presence of many Langerhans cells
within the epidermis. (c) High TSLP expression in atopic dermatitis skin lesion
samples, which is associated with the presence of many activated DC-LAMP+ DCs
in epidermis and dermis. (d) Many of the DC-LAMP+ DCs within the dermis in c
express langerin.
•
july 2002
c
b
d
Methods
keratinocytes of atopic dermatitis and TSLP-DCs strongly prime naïve
CD4+ T cells to produce IL-13, IL-5 and TNF-α suggest that TSLP likely represents the missing critical factor, which is key to understanding
the pathogenesis of allergic diseases. TSLP produced by epithelial cells,
or other stromal cells at the site of antigen entry, may activate DCs and
stimulate them to produce TH2-attracting chemokines such as TARC and
MDC. Migration of TSLP-DCs to the draining lymph nodes would
induce allergen-specific T cell proliferation and differentiation into TH2
cells. These allergen-specific TH2 T cells may then migrate back towards
TARC and MDC, within the original site of inflammation, to trigger
allergic inflammation. Indeed, T cell infiltration was found in skin samples from all the atopic derematitis patients tested in another study37. In
addition, skin-homing T cells from atopic dermatitis produce TH2
cytokines38. Therefore, our work provides a direct functional link
between epithelial cells, DCs and T cell–mediated immune responses.
Unlike classical TH2 cells, which produce IL-4, IL-5, IL-10 and IL13, human CD4+ T cells primed with TSLP-DCs produce high IL-13
and IL-5, moderate IL-4 but little IL-10. Although, historically, IL-10
has been included as a TH2 cytokine27, its contribution to the TH2-mediated allergic inflammation has been controversial. Some studies
showed that IL-10 mRNA levels in the lung, gut and skin were
increased in patients with allergic asthma or atopic dermatitis39.
However, direct measurement of IL-10 protein by ELISA showed
markedly lower amounts of IL-10 in the bronchealveolar lavage or in
the culture supernatants of activated peripheral blood mononuclear
cells from atopic patients compared to normal control subjects40.
Studies in mouse models confirm a role for IL-10 in suppressing airway
inflammation and cytokine production41,42. Therefore, high concentrations of IL-13, IL-5 and TNF-α, moderate amounts of IL-4 and
decreased production of IL-10 and IFN-γ by TSLP-DCs activated T
cells and may represent the real allergic inflammatory cytokines that
underlie the pathophysiology of atopic dermatitis or asthma.
Historically, the study of allergic diseases has been focused on the
effector cells, such as mast cells and eosinophils. TH2 cells and DCs are
implicated as playing key roles in the upstream steps of allergic
inflammation. Our study indicates that epithelial cells may well provide
the initial trigger of the allergic immune cascade. Epithelial
cell–derived TSLP not only potently activates DCs, but also endows
DCs with the ability to polarize naïve T cells to produce proallergic TH2
cytokines. TSLP may represent a new target to block inflammatory diseases, in particular allergic diseases.
http://immunol.nature.com
a
DC purification and culture. CD11c+ DCs were purified from the adult blood buffy coats
of healthy volunteer blood donors (Stanford Medical School Blood Center, Stanford, CA)
after separation of peripheral blood mononuclear cells (PBMC) by Ficoll centrifugation and
negative depletion of cells that were expressing CD3, CD14, CD19, CD56 and glycophorin
A with magnetic beads (Dynal, Oslo, Norway). Depleted cells were further stained with tricolor(TC)-conjugated anti-CD4 (Caltag, Burlingame, CA), phycoerythrin (PE)–antiCD11c, anti-CD3, anti-CD14 and fluorescein isothiocyanate (FITC)–anti-CD16 (Becton
Dickinson, Franklin Lakes, NJ). FITC-CD11c+ cells were isolated with a Vantage FACsorter
(Becton Dickinson) to reach >99% purity. CD11c+ DCs were cultured immediately after
sorting in RPMI containing 10% fetal calf serum (FCS), 1% pyruvate, 1% HEPES and penicillin-streptomycin. Cells were seeded at 0.5 × 106/ml in flat-bottomed 96-well plates in the
presence of TSLP (15 ng/ml), IL-7 (50 ng/ml), LPS (1 µg/ml), CD40L-transfected L-fibroblasts (2.5 × 104/well) or culture medium alone.
DC activation and viability. After 24 h of culture, DCs were collected and resuspended in
an EDTA-containing medium to dissociate the clusters. Viable DCs were first counted with
trypan blue exclusion of dead cells. Remaining cells were stained with FITC-conjugated
mouse anti-human mAbs that included anti–HLA-DR (Becton Dickinson), anti-CD40, antiCD80 and anti-CD86 (all from Pharmingen, San Diego, CA) and an IgG1 isotype control
(Becton Dickinson); they were analyzed with a FACScan flow cytometer (Becton
Dickinson). Dead cells were excluded based on side- and forward-scatter characteristics.
For apoptosis detection, cells were stained for 5–10 min with FITC–annexin V (Promega,
Madison, WI) and analyzed on a FACScan flow cytometer (Becton Dickinson) without
dead-cell exclusion.
DC cytokine production. DC culture supernatants were collected at 24 h, frozen at –80 °C
and analyzed within 3 months with protein ELISA kits for IL-1β, IL-6, IL-12p70, TNF-α,
TARC, MDC, MIP-1β and RANTES (all from R&D Systems, Minneapolis, MN).
DC–T cell cocultures. CD11c+ DCs were collected after 24 h of culture under different
conditions, washed twice to remove any cytokine and cocultured with 5 × 104 freshly purified allogeneic naïve CD4+ T cells in round-bottomed 96-well culture plates. Cultures were
done in triplicate at increasing DC:T cell ratios. DCs and T cells alone were used as controls. After 5 days, cells were pulsed with 1 mCi [3H]thymidine (Amersham Biosciences,
Piscataway, NJ) for 16 h before collecting and counting radioactivity.
T cell cytokine production. After 6 days of coculture, DC-primed CD4+ T cells were restimulated for 24 h with plate-bound anti-CD3 (10 µg/ml) and soluble anti-CD28 (2 ng/ml).
Cytokine production was assessed in the culture supernatant by protein ELISA for IL-4,
IL-5, IL-10, IL-13, TNF-α and IFN-γ (all from R&D Systems). For intracellular
cytokine production, T cells were collected on day 6 of the culture, washed twice and
restimulated with PMA + ionomycin in flat-bottomed 96- or 48-well plates at a concentration of 1 × 106/ml. After 2.5 h, brefeldin A was added at 10 mg/ml. After 5 h, cells
were collected, fixed with 2% formaldehyde, permeabilized with 10% saponin and
stained with PE-conjugated mAbs to IL-4, IL-5, IL-10, IL-13 and ΤΝF-α and FITC-conjugated anti–IFN-γ (all from Pharmingen). Stained cells were analyzed on a FACScan
flow cytometer (Becton Dickinson).
Quantification of TSLP mRNA in human primary cells. Cryopreserved primary human
fibroblasts, epithelial cells, smooth muscle cells, endothelial cells were from Clonetics
(Biowhittaker, San Diego, CA), and seeded at 2500–3500 cells/cm2 in T75 flasks with the
appropriate fully supplemented culture medium (Biowhittaker). After two or three passages,
•
volume 3 no 7
•
nature immunology
679
© 2002 Nature Publishing Group http://immunol.nature.com
A RTICLES
cells were collected by light trypsinization and reseeded in 12 or 6-well plates (5 × 105
cells/well) under different culture conditions, with or without addition of cytokines. After
12–15 h, culture supernatants were collected, adherent cells were lysed, mRNA was extracted with a Qiagen kit (Qiagen, Valencia, CA) and analyzed by real-time quantitative PCR.
Mast cells were generated from human CD34+ stem cells cultured with stem cell factor.
Final culture contained >95% CD117+CD14–CD16– mast cells. Activation was initiated by
cross-linking of the high-affinity IgE receptor with the DX55 mAb (J. Philips, DNAX, Palo
Alto, CA). DCs and DC precursors (>99% purity) were isolated by cell-sorting peripheral
blood cells as described43. The following freshly sorted peripheral blood cell subsets, before
and after culture, were used for the Taqman-PCR analyses: monoctyes; monocyte-derived
immature DCs (imDCs, monocytes cultured for 6 days with GM-CSF and IL-4); monocytederived mature DCs activated by CD40L (CD40L-mDC) or LPS (LPS-mDCs);
CD4+Lin–CD11c– plasmacytoid DC precursors (pDC2); pDC2-derived DCs induced by IL3 (IL-3-DC2) or by HSV-1 (HSV-DC2); CD11c+ DCs (CD11c+ DCs); CD11c+ DCs activated by CD40L (CD40L-CD11c+ DCs) or by LPS (LPS-CD11c+ DCs); monocyte-derived
macrophages (monocyte cultured for 6 d with M-CSF); and freshly isolated CD68+CD16+
neutrophils, CD16+CD56+ NK cells, CD19+ B cells and CD3+ T cells. For other cell types,
cDNA libraries were prepared and used as templates for Taqman-PCR analyses as
described17. Results are expressed as mRNA levels relative to ubiquitin.
6. Holgate, S.T. Science, medicine, and the future. Allergic disorders. Brit. Med. J. 320, 231–234 (2000).
7. Busse,W.W. & Lemanske, R. F. Jr. Asthma. N. Engl. J. Med. 344, 350–362 (2001).
8. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252
(1998).
9. Holt, P. G. Macrophage: dendritic cell interaction in regulation of the IgE response in asthma. Clin.
Exp. Allergy 23, 4–6 (1993).
10. Lambrecht, B. N. et al. Myeloid dendritic cells induce TH2 responses to inhaled antigen, leading to
eosinophilic airway inflammation. J. Clin. Invest. 106, 551–559 (2000).
11. Semper, A. E., Gudin, A. M., Holloway, J. A. & Holgate, S.T. in Dendritic Cells (eds. Lotze, M.T. &
Thomson, A.W.) 435–456 (Academic Press, San Diego, CA,1999).
12. Stingl, G. in Immunological and Pharmacological Aspects of Atopic and Contact Eczema (ed.
Czernielewski, J .M.) 1–9 (Karger, Basel, 1991).
13. Sims, J. E. et al. Molecular cloning and biological characterization of a novel murine lymphoid growth
factor. J. Exp. Med. 192, 671–680 (2000).
14. Tonozuka,Y. et al. Molecular cloning of a human novel type I cytokine receptor related to δ/TSLPR.
Cytogenet. Cell Genet. 93, 23–25 (2001).
15. Pandey, A. et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nature Immunol. 1, 59–64 (2000).
16. Park, L. S. et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of
a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 192, 659–670 (2000).
17. Reche, P. A. et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells.
J. Immunol. 167, 336–343 (2001).
18. Ray, R. J., Furlonger, C.,Williams, D. E. & Paige, C. J. Characterization of thymic stromal–derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur. J. Immunol. 26, 10–16 (1996).
19. Levin, S. D. et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B
cells in vitro and signals via a novel mechanism. J. Immunol. 162, 677–683 (1999).
20. Koch, F. et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II
and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184, 741–746 (1996).
21. Cella, M. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12
and enhances T cell stimulatory capacity:T-T help via APC activation. J. Exp. Med. 184, 747–752 (1996).
22. Pulendran, B. et al. Distinct dendritic cell subsets differentially regulate the class of immune response
in vivo. Proc. Natl. Acad. Sci. USA 96, 1036–1041 (1999).
23. Maldonado-Lopez, R. et al. CD8α+ and CD8α– subclasses of dendritic cells direct the development
of distinct T helper cells in vivo. J. Exp. Med. 189, 587–592 (1999).
24. Rissoan, M. C. et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283,
1183–1186 (1999).
25. Homey, B. & Zlotnik, A. Chemokines in allergy. Curr. Opin. Immunol. 11, 626–634 (1999).
26. Moore, K.W., de Waal Malefyt, R., Coffman, R. L. & O’Garra, A. Interleukin-10 and the interleukin-10
receptor. Annu. Rev. Immunol. 19, 683–765 (2001).
27. O’Garra, A. Cytokines induce the development of functionally heterogeneous T helper cell subsets.
Immunity 8, 275–283 (1998).
28. Vestergaard, C. et al. A TH2 chemokine,TARC, produced by keratinocytes may recruit CLA+CCR4+
lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115, 640–646 (2000).
29. Imai,T. et al. Selective recruitment of CCR4-bearing TH2 cells toward antigen-presenting cells by the
CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
Int. Immunol. 11, 81–88 (1999).
30. Andrew, D. P. et al. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both TH1 and TH2 potential. J. Immunol. 166, 103–111 (2001).
31. de Saint-Vis, B. et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon
DC maturation, is transiently expressed in MHC class II compartment. Immunity 9, 325–336 (1998).
32. Hammad, H. et al. TH2 polarization by Derp 1–pulsed monocyte-derived dendritic cells is due to the
allergic status of the donors. Blood 98, 1135–1141 (2001).
33. McWilliam, A. S. et al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184, 2429–2432 (1996).
34. Novak, N., Haberstok, J., Geiger, E. & Bieber,T. Dendritic cells in allergy. Allergy 54, 792–803 (1999).
35. Tunon-De-Lara, J. M. et al. Dendritic cells in normal and asthmatic airways: expression of the α subunit of the high affinity immunoglobulin E receptor (Fcε RI-α). Clin. Exp. Allergy 26, 648–655 (1996).
36. Holt, P. G., Macaubas, C., Cooper, D., Nelson, D. J. & McWilliam, A. S.Th-1/Th-2 switch regulation in
immune responses to inhaled antigens. Role of dendritic cells in the aetiology of allergic respiratory
disease. Adv. Exp. Med. Biol. 417, 301–306 (1997).
37. Homey B. et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nature Med.
8, 157–65 (2002).
38. Romagnani S.T-cell responses in allergy and asthma. Curr. Opin. Allergy. Clin. Immunol. 1, 73–78 (2002).
39. Robinson, D. S. et al. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am. J. Respir. Cell. Mol. Biol. 14, 113–117 (1996).
40. Borish, L. et al. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy. Clin.
Immunol. 97, 1288–1296 (1996).
41. Akbari, O., DeKruyff, R. H. & Umetsu, D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2, 725–731 (2001).
42. Zuany-Amorim, C. et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways
of sensitized mice. J. Clin. Invest. 95, 2644–2651 (1995).
43. Siegal, F. P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science
284, 1835–1837 (1999).
Skin biopsy samples. After obtaining informed consent from patients, 3–6 mm punch biopsies were taken from either lesional or nonlesional skin from atopic dermatitis (n = 15) or
disseminated lupus erythematosus patients (n = 5) or from normal healthy individuals (n =
11). Patients with a history of allergic contact dermatitis against nickel (n = 8) underwent
diagnostic nickel patch tests, and skin biopsies (three per patient) were taken before and 6,
24 or 48 h after allergen exposure. Skin samples were immediately frozen in liquid nitrogen and stored at –80 °C. The study was approved by the local ethics committees of the
Department of Medicine of the Helsinki-Uusimaa Hospital District, Finland and the
Heinrich-Heine University, Dusseldorf, Germany.
Immunohistology. Frozen sections (8 µm) of human tonsil or skin were incubated with rat
anti–human TSLP (mAb 12F3, DNAX, Palo Alto, CA) at room temperature for 1 h in PBS.
The slides were washed with PBS twice and incubated with biotinylated secondary antibody
for 30 min (PK-4004, Vector Laboratories, Burlingame, CA). The slides were washed and
incubated with avidin-peroxidase complex reagents for 30 min (PK-4004, Vector
Laboratories). The slides were washed and incubated with substrate SK-4200, which
stained red (Vector Laboratories). For double staining of human TSLP with DC-LAMP or
langerin, the slides were incubated with mouse anti–human DC-LAMP (IM3448) or mouse
anti–human langerin (IM3449, Immunotech, Marseille, France) for 1 h; this was followed
by red anti-TSLP staining. The slides were washed and incubated with biotinylated
anti–mouse Ig (AK-5002, Vector Laboratories), then the avidin-peroxidase complex
reagents (AK-5002, Vector Laboratories) for 30 min each. The slides were washed and the
incubated with the substrate SK-5300, which stained blue (Vector Laboratories).
Acknowledgments
We thank L. Lanier, J.-Z. Chen and J. Banchereau for critical reading of the manuscript and
M. Andonian for help with graphics. DNAX Research Institute is supported by ScheringPlough.
Competing interests statement
The authors declare competing financial interests: see the Nature Immunology website
(http://immunology.nature.com) for details.
Received 27 March 2002; accepted 15 May 2002.
1. Kay, A. B. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30–37 (2001).
2. Mosmann,T. R. & Coffman, R. L.TH1 and TH2 cells: different patterns of lymphokine secretion lead to
different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
3. Abbas, A. K., Murphy, K. M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383,
787–793 (1996).
4. Constant, S. L. & Bottomly, K. Induction of TH1 and TH2 CD4+ T cell responses: the alternative
approaches. Annu. Rev. Immunol. 15, 297–322 (1997).
5. Renauld, J. C. New insights into the role of cytokines in asthma. J. Clin. Pathol. 54, 577–589 (2001).
680
nature immunology
•
volume 3 no 7
•
july 2002
•
http://immunol.nature.com